The 2026 #ASCOAdvocacySummit and online Week of Action start today! Join us in urging Congress to:
- Prioritize federal research funding
- #FixPriorAuth
- Permanently extend Medicare telehealth flexibilities
Learn more: https://bit.ly/4sFU3Zs
#ASCOConnection covers a new special series in #JCOCCI that explores the practical application of large language models (LLMs) and their impact on #CancerCare delivery.
Read more: connection.asco.org/do/navigating-opportunit...
#LLM
Following FDA approval of lifileucel for advanced melanoma in early 2024, U.S. centers have been learning how to best deliver this novel “living” drug. For #ASCODailyNews, @maxjulve.bsky.social & @drbetofmdphd.bsky.social discuss the real-world challenges facing clinicians: https://bit.ly/48nBPor
Dr. Monty Pal of @cityofhope.bsky.social & @drbonillaonc.bsky.social of St. Luke's University Health Network discuss the risks of implementing #AI in clinical practice & approaches to help oncologists maintain their decision-making agility on the latest #ASCODailyNews Podcast: https://bit.ly/4dQrp43
In our social media coverage of #ASCO26, who do you want to hear from?
1️⃣ Abstract authors
2️⃣ ASCO leadership
3️⃣ Attendees
4️⃣ Presenters and speakers
📊 Show results
For Chief Quality Officer Maria Koslosky, local cancer care in Dillon, MT, is the difference between being a traveler and being a neighbor.
By reducing “time toxicity,” she can stay focused on her career and her next triathlon finish line.
Read her story: https://bit.ly/4220D1p
Time is ticking! Join the oncology community on May 12 for the Fourth Annual TAPUR Virtual Grand Rounds. As we celebrate a decade of advancing precision medicine, this is your chance to hear directly from founding TAPUR experts.
Register today: https://bit.ly/485rXza
#TAPURStudy #PrecisionOncology
Help shape the future of Nasopharyngeal Carcinoma treatment. Our new draft guidelines are now available for your expert feedback.
Directly impact clinical standards—submit by April 24: https://bit.ly/4txMhS2
#NPC
Dr. Inemesit Akpan provides guidance for those looking to take the first step to becoming an oncologist with clarity and compassion for themselves.
Read more: https://bit.ly/4sfn7qh
#ASCOConnection
We’re really excited about #ASCO26 and covering the meeting on our social channels. We want to know what types of coverage you’re most interested in:
1️⃣ Behind-the-scenes videos & photos
2️⃣ More session footage/info
3️⃣ Interviews with authors
4️⃣ Expert perspectives on sessions/abstracts
📊 Show results
Asia Pacific institutions -- See what it’s like to be a host institution in our latest blog post about our partnership in Sarawak: connection.asco.org/do/asco-and-...
DEADLINE EXTENDED: Applications for the ASCO International Cancer Corps are now open through April 14!
Apply now: https://bit.ly/4mf8ZMq
#ASCOGlobalImpact
Join us in congratulating the following members on earning the Fellows of ASCO (FASCO) distinction last quarter! We are grateful for their extraordinary volunteer service, dedication, and commitment to ASCO.
Learn more about FASCO distinction: https://bit.ly/4sOL1Kn
Don’t get left behind! ⏰ Early registration for #ASCO26 closes soon. Secure your discounted spot at The Place to Be for the global oncology community by registering before April 22 at 11:59 PM (ET). We can't wait to see you! https://bit.ly/4cckyBd
"I believe ASCO’s principles and commitment to advancing patient care reflect my own values."
Dr. Yeku highlights the power of mentorship and networking within the ASCO community. Elevate your oncology career with a global network of peers.
Join us: https://bit.ly/3OdHrdT
April is #GlobalVolunteerMonth. Our CEO Dr. @cliffordhudis.bsky.social expresses a heartfelt ‘thank you’ to our volunteers for their time, thought leadership, and expertise. Thank you for your service to ASCO today & every day!
Get involved: https://bit.ly/47ypYmV
Dr. Sumanta Pal of @cityofhope.bsky.social discusses the impact of the groundbreaking AQUILA trial in high-risk smoldering multiple myeloma with @vincentrk.bsky.social of Mayo Clinic & @szusmani.bsky.social of @mskcancercenter.bsky.social on the latest #ASCODailyNews Podcast: https://bit.ly/41FCEVw
New evidence-based recommendations for thyroid cancer systemic therapy are now available.
Covering:
✅ Well-differentiated
✅ Differentiated high-grade
✅ Poorly differentiated
✅ Anaplastic & Medullary
Read the full article: https://bit.ly/48jVCEV
Celebrating a decade of research. Join founding PI Dr. Richard Schilsky & TAPUR experts on May 12 for the Fourth Annual TAPUR Virtual Grand Rounds.
Tune in to explore TAPUR’s decadelong impact & its future in clinical research.🧬
Register today: https://bit.ly/485rXza
With three more ASCO meetings this year, there are still plenty of opportunities to connect with peers, discover groundbreaking cancer research, & gain clinical insights. Don't miss out on our meetings—the ultimate Place to Be.
Where will we see you this year?
The draft guideline protocol for "Treatment of Patients with Invasive #CervicalCancer" is open for comments. Please review and submit your comments by April 7 to help shape final recommendations.
Read & comment here: https://bit.ly/4sUHji8
Mr. Anthony Cuandros reflects on what being a research assistant in Dr. Misty Shields’ laboratory taught him about the fight for “one more lap” shared by patients and oncology care professionals alike.
Learn more: https://bit.ly/3Pv1CUJ
#ASCOConnection
Time is running out! Apply by March 30th for the @conquercancer.bsky.social YIA in Early Cancer Detection and get funding to advance your career.
Apply today: https://bit.ly/4s4Qj4l
#CancerResearch
“Patients with cancer should not have to fight paperwork to get the care they need at a time they need it most.” ASCO member Dr. Chancellor Donald weighs in on how Medicaid work reqs could disrupt lifesaving care in Louisiana. Read more: https://bit.ly/4lBpG4i
#ASCOAdvocacy
Based on recent study results, bevacizumab + erlotinib could represent a significant advance for some renal cell carcinoma subtypes. For #ASCODailyNews, Dr. Pavlos Msaouel of @mdanderson.bsky.social discusses tailoring therapy for these rare and aggressive diseases: https://bit.ly/40zFjQj
Sunrise to sunset with ASCO member Dr. Knoll of Northwell Health! 🏋️♀️ A radiation oncology powerhouse mastering high-tech machinery and a busy mom, juggling it all. 🛡️💻 #RadOnc
For some patients with extensive-stage small cell lung cancer who achieve prolonged disease control with immunotherapy, an indefinite ICI break may be appropriate. Kelsey Pan, MD, MPH
& @ramalingammd.bsky.social discuss in a new editorial for #ASCODailyNews: https://bit.ly/40E8IJ7
Medoncs @lungoncdoc.bsky.social & Dr. Shruti Patel met at the 2021 ASCO Annual Meeting & have been friends & collaborators ever since. Who will you connect with at #ASCO26?
Don’t miss your connection; register today: https://bit.ly/4ut3rBX
The draft guideline update protocol for "First-Line Systemic Treatment for Metastatic Hormone-Sensitive Prostate Cancer" is open for comments. Please review and submit your comments by March 26 to help shape final recommendations.
Learn more: https://bit.ly/40WtFyV
"Shared decision making is an essential part of oncology. When done well, it ensures that a patient’s treatment plan aligns with their goals and values and promotes autonomy," Drs. Adam René P. Rosenbaum, Christy Lucas, and Abby Rosenberg said.
Read more: https://bit.ly/40ruTlG
#ASCOConnection
